Samuel Allemann
Impact in
- Family Practice top 1%
- Medication Adherence and Compliance
- Geriatrics and Gerontology top 2%
- Pharmaceutical Practices and Patient Outcomes
Papers in
-
- Medication Adherence and Compliance 22
-
- Pharmaceutical Practices and Patient Outcomes 13
- Co-authors
- Kurt E. HersbergerLea BotermannNina GrieseJ. W. Foppe van MilKarin BergerIsabelle ArnetRobby NieuwlaatAlexandra L. Dima
- Journals
- Pharmacogenomics and Personalized Medicine (4 papers)British Journal of Clinical Pharmacology (3 papers)International Journal of Clinical Pharmacy (3 papers)Frontiers in Pharmacology (3 papers)Frontiers in Psychiatry (2 papers)
- Partner nations
- SwitzerlandFranceUnited States
In The Last Decade
Samuel Allemann
43 papers receiving 414 citations
Peers
Comparison fields: 5 of 85
- Family Practice 180
- Geriatrics and Gerontology 183
- Applied Microbiology and Biotechnology 20
- Pharmacology 61
- Pediatrics, Perinatology and Child Health 133
Countries citing papers authored by Samuel Allemann
This map shows the geographic impact of Samuel Allemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel Allemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel Allemann more than expected).
Fields of papers citing papers by Samuel Allemann
This network shows the impact of papers produced by Samuel Allemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel Allemann. The network helps show where Samuel Allemann may publish in the future.
Co-authors
The 25 scholars most cited alongside Samuel Allemann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 2 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 3 | |
| 7 | 2024 | 2 | |
| 8 | 2024 | 1 | |
| 9 | 2024 | 2 | |
| 10 | 2024 | 3 | |
| 11 | 2023 | 4 | |
| 12 | 2023 | 3 | |
| 13 | 2023 | 1 | |
| 14 | 2022 | 11 | |
| 15 | 2022 | 12 | |
| 16 | 2022 | 3 | |
| 17 | 2021 | 2 | |
| 18 | 2021 | 12 | |
| 19 | 2020 | 1 | |
| 20 | 2019 | 8 |
About Samuel Allemann
Samuel Allemann is a scholar working on Family Practice, Geriatrics and Gerontology, Pharmacology, Pediatrics, Perinatology and Child Health and Biological Psychiatry, having authored 52 papers that have together received 424 indexed citations. Recurring topics across this work include Medication Adherence and Compliance (22 papers), Pharmaceutical studies and practices (17 papers), Pharmacogenetics and Drug Metabolism (14 papers), Pharmaceutical Practices and Patient Outcomes (13 papers), Bipolar Disorder and Treatment (12 papers), Pharmacological Effects and Toxicity Studies (4 papers), Treatment of Major Depression (3 papers) and Pharmaceutical Economics and Policy (3 papers). The work is most often cited by research in Family Practice (180 citations), Geriatrics and Gerontology (183 citations), Applied Microbiology and Biotechnology (20 citations), Pharmacology (61 citations) and Pediatrics, Perinatology and Child Health (133 citations). Samuel Allemann has collaborated with scholars based in Switzerland, France and United States. Frequent co-authors include Kurt E. Hersberger, Lea Botermann, Nina Griese, J. W. Foppe van Mil, Karin Berger, Isabelle Arnet, Robby Nieuwlaat, Alexandra L. Dima, Bart J. F. van den Bemt and Henriette E. Meyer zu Schwabedissen. Their work appears in journals such as Pharmacogenomics and Personalized Medicine, British Journal of Clinical Pharmacology, International Journal of Clinical Pharmacy, Frontiers in Pharmacology and Frontiers in Psychiatry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.